Our People

Tyra has built a nimble and experienced team to rapidly translate new discoveries into the clinic with a singular focus on acquired resistance in oncology.

Board Members

Bob More

Sid Subramony

Gilla Kaplan

Nina Kjellson

Todd Harris

Isan Chen

Jake Simson

Company

Robert L. Hudkins

Esther van den Boom

Lindy Schermerhorn

Dan Bensen

Todd Harris

Mike Riley

Ronald V. Swanson

Eric Allen

Piyush Patel

Scientific Advisors

Jeffrey Hager

William Hahn

Jason Sheltzer

Peter Smith

Investors

venture-Alta

venture-RA-Capital

venture-Boxer-Capital

venture-Canaan